MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 197 filers reported holding MYRIAD GENETICS INC in Q1 2021. The put-call ratio across all filers is 0.68 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $261,000 | -6.5% | 13,672 | -10.9% | 0.99% | +21.1% |
| Q2 2022 | $279,000 | -21.0% | 15,352 | +9.7% | 0.82% | +1.1% |
| Q1 2022 | $353,000 | -9.9% | 13,991 | -1.5% | 0.81% | +29.3% |
| Q4 2021 | $392,000 | -37.6% | 14,209 | -26.9% | 0.63% | -17.6% |
| Q3 2021 | $628,000 | -31.1% | 19,448 | -34.8% | 0.76% | -28.8% |
| Q2 2021 | $912,000 | -9.4% | 29,837 | -9.7% | 1.07% | -3.6% |
| Q1 2021 | $1,007,000 | +401.0% | 33,060 | +658.1% | 1.11% | +1105.4% |
| Q3 2018 | $201,000 | -44.5% | 4,361 | -64.4% | 0.09% | -29.2% |
| Q1 2018 | $362,000 | +26.1% | 12,248 | +46.5% | 0.13% | +34.0% |
| Q4 2017 | $287,000 | -20.9% | 8,362 | -16.7% | 0.10% | -17.8% |
| Q3 2017 | $363,000 | +55.1% | 10,035 | +11.0% | 0.12% | +61.6% |
| Q2 2017 | $234,000 | – | 9,040 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SCOPIA CAPITAL MANAGEMENT LP | 6,459,139 | $278,776,000 | 5.53% |
| Tieton Capital Management, LLC | 119,290 | $5,149,000 | 4.04% |
| RPg Family Wealth Advisory, LLC | 97,202 | $4,195,238,000 | 3.85% |
| RK Capital | 384,900 | $16,612,000 | 2.90% |
| Contrarius Investment Management Ltd | 652,288 | $28,153,000 | 2.65% |
| S&T BANK/PA | 331,885 | $14,324,000 | 2.22% |
| Euclidean Technologies Management, LLC | 40,917 | $1,766,000 | 1.90% |
| AIMZ Investment Advisors, LLC | 45,635 | $1,970,000 | 1.80% |
| Taylor Frigon Capital Management LLC | 34,783 | $1,486,000 | 1.67% |
| KILLEN GROUP INC | 366,305 | $15,810,000 | 1.63% |